Golimumab

Golimumab
Measuring Golimumab drug concentrations in patients being treated with Golimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Golimumab allows for reliable measurement of Golimumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Golimumab immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum, Plasma
• Reaction Time 10 mins
  
• Detection Range 0.20-30 μg/mL
  
• Indication Quantitative determination of free Golimumab in human whole blood/serum/plasma
  

Click